Next Article in Journal
What Is the State-of-the-Art in Clinical Trials on Vaccine Hesitancy 2015–2020?
Next Article in Special Issue
Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine
Previous Article in Journal
COVID-19’s Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older
Previous Article in Special Issue
Evaluation of DNA-Launched Virus-Like Particle Vaccines in an Immune Competent Mouse Model of Chikungunya Virus Infection
 
 
Review

Article Versions Notes

Vaccines 2021, 9(4), 347; https://doi.org/10.3390/vaccines9040347
Action Date Notes Link
article xml file uploaded 5 April 2021 10:28 CEST Original file -
article xml uploaded. 5 April 2021 10:28 CEST Update https://www.mdpi.com/2076-393X/9/4/347/xml
article pdf uploaded. 5 April 2021 10:28 CEST Version of Record https://www.mdpi.com/2076-393X/9/4/347/pdf
article html file updated 5 April 2021 10:29 CEST Original file -
article html file updated 11 April 2021 07:12 CEST Update -
article html file updated 11 April 2021 07:21 CEST Update -
article html file updated 4 August 2021 07:49 CEST Update -
article html file updated 4 August 2021 07:49 CEST Update -
article html file updated 25 July 2022 10:48 CEST Update https://www.mdpi.com/2076-393X/9/4/347/html
Back to TopTop